Schröder R, Johansson L, Mueller T C. "一种的合成方法" [P]. European Patent, EP 3544831 A1, 2021-09-22.
发明人高志强,刘建华,胡光. "Method for the Synthesis of N-[6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide" [P]. 中国发明专利, 专利号 CN 117515088 B, 授权公告日 2023-09-05.
发明人韩伟,黄志刚,朱建伟. "A Process for Preparing High-Purity N-[6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide" [P]. 中国发明专利, 专利号 CN 115400840 A, 授权公告日 2024-09-21.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2013, 277, (6), 1369-1398.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2018, 1279, 6975-6999.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of N-[6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide Using HRMS and NMR". Anal. Chim. Acta, 2012, 2138, (12), 7110-7123.